Citation Tools
PDFClinical/translational cancer immunotherapy
Original research
Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses